Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.2113
+0.0093 (4.60%)
Feb 24, 2026, 10:33 AM EST - Market open
Iterum Therapeutics Market Cap
Iterum Therapeutics has a market cap or net worth of $11.16 million as of February 24, 2026. Its market cap has decreased by -72.77% in one year.
Market Cap
11.16M
Enterprise Value
33.41M
1-Year Change
-72.77%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since May 25, 2018, Iterum Therapeutics's market cap has decreased from $179.38M to $11.16M, a decrease of -93.78%. That is a compound annual growth rate of -30.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 10.67M | -39.70% |
| Dec 31, 2025 | 17.70M | -63.66% |
| Dec 31, 2024 | 48.70M | 84.01% |
| Dec 29, 2023 | 26.47M | 157.57% |
| Dec 30, 2022 | 10.28M | -85.65% |
| Dec 31, 2021 | 71.61M | 47.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoMed Therapeutics | 12.12M |
| BioCardia | 11.99M |
| Moolec Science | 11.92M |
| Kairos Pharma | 11.56M |
| Soligenix | 11.09M |
| Phio Pharmaceuticals | 11.09M |
| Imunon | 10.95M |
| KALA BIO | 10.73M |